NDLI: Group B streptococcal infections in elderly adults.

Please wait, while we are loading the content...

Group B streptococcal infections in elderly adults.

Content Provider	Semantic Scholar
Author	Edwards, Morven S. Baker, Carol J.
Copyright Year	2005
Abstract	Elderly adults account for >40% of persons with invasive group B streptococcal (GBS) disease and for >50% of GBS-associated deaths in the United States. The prevalence of colonization among healthy elderly adults (approximately 25%) is similar to that among women of childbearing age. Delineating contributions of comorbid conditions, altered integrity of anatomical barriers, and abnormalities in immune responses caused by immune senescence to pathogenesis require further investigation. Delayed clinical recognition of illness may contribute to poor outcome. Skin and soft-tissue infections and bacteremia with no identified focus are common manifestations of infection in elderly adults and younger nonpregnant adults. Urinary tract infection and pneumonia are presentations more often encountered in elderly persons than in younger adults. The safety and immunogenicity of GBS serotype V-tetanus toxoid conjugate vaccine in healthy elderly persons suggest the potential for vaccination as an approach to prevention of invasive GBS infections in elderly persons.
Starting Page	1
Ending Page	2
Page Count	2
File Format	PDF HTM / HTML
Alternate Webpage(s)	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/41/6/10.1086/432804/3/41-6-839.pdf?Expires=1492389528&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q&Signature=AQr62B-k6FjvGWaR89s5sH5QQ11del-drrTTau9Wi58~6LUDfvAoBMC8atcgj-SB0DyH5uBct-7MUstx0N2akeSz2~zX7mju~01D1rAtmxHoEeRowssQEBdmecF-IKMgX-M6UuRdYz9V-HNtrEYb4XAVCKGYDIwWWf~mG50e7ACdCSp8NpOiS9fOvMHz8x1EwCH41rCdogR9u8q1mdvRobYmVL46hz1V0iwbRXksJIsoOC~FB7GX4uG1Z5AimMDHV6c3L4Aa4h-ukCioM9mkDgN4JC3iALaGpgvCphR8phDDhEPkT12jTKE3ZpSrXkytVH10FUMR2vcpNaFj~xdOuw__
Alternate Webpage(s)	https://watermark.silverchair.com/41-6-839.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAZ0wggGZBgkqhkiG9w0BBwagggGKMIIBhgIBADCCAX8GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM0kcaNBXp4jeRAx4DAgEQgIIBUBL5_MUnSTg8yRtBJVlpfwWJd_sPGJM8xbUf_32M8JQ5EjGBwmeYzVor9ynQlOyAHQa2gv2RdDXB_I9CZKnzypsVque3svfdieQx-oGxAJLr7XFKKWXO3ADf93WTF_qJUrT5WGjbCWZvhLqEEmzcW3h1hh3R_ZHaM_fJUgrPk9BO_woBLH5E9DTxLfoVA0kQSvpxrOeMIUL6PzCcNTohkEXgLmKs8fVvMGhpD5zSl4lpTaA3P8mYgHX0Fb2wyIsFDrQ9259g6AG8M45TCWAC6JcGHMrswOqdNtKkG0d2tl6WlaHhENm_oT6CGzHH6nV7Smp7GHKf26lJszi1sRiFymlkBGOTyeBi7nZPrU8tvHJc7vR3plILeB6Pqd9-ujV1dgwOn0UKFUaeI_gJJbM-GAql-OJsVY5Fy9f5ojOGrSsJlR0O02GDpik3j9ZnldFosg
Alternate Webpage(s)	https://watermark.silverchair.com/41-6-839.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAZowggGWBgkqhkiG9w0BBwagggGHMIIBgwIBADCCAXwGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMS7aYriixL78ACHljAgEQgIIBTdnJUHero0b0r0gI2y1_lTJgSVFABoNYtvBlB2GpYEIScX_Frfg5Iid735O9G527dcLalO2729TnHxqvpT3OY4QXPaHKlP8oz5VebygY8e0j6oP08c7bDYZYKJXQxuLZsC-JwrWullxohg7ZOVXSe7QhqKDNLST8yr0o6xgEuWLkkOHkySwqqFriuVVP59Lqr6t4KS2XVlZVeAPrPxUmDMotgrN-t-DnnQpaEfFkySFUbpMETLXPhSTB6ROHilXPONnXYXNyHlH8oLPqWvwl33nnJVcOryfpTBnOWX6BL9-aDOzgvSQst4HwZAP1nttZ-jvxdaDHQpYG2ZDgZA-6rhageoiBHX5KjMESAVkWx6KbZ5to2zgIYV0phlP3VEyCmdOPHpjxmxw3A15o_4bAILfRp_qklFs3DDDiU1OKL69UCEQ1uPhlfUXwrkaHpQ
PubMed reference number	16107984v1
Volume Number	41
Issue Number	6
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Language	English
Access Restriction	Open
Subject Keyword	Bacteremia Cessation of life Congenital Abnormality Illness (finding) Immune response Immunostimulating conjugate (antigen) Paget's Disease, Mammary Streptococcal Infections Streptococcal pneumonia Surgical Wound Infection Toxoids Urinary tract infection Vaccines, Conjugate tetanus toxoid vaccine, inactivated
Content Type	Text
Resource Type	Article

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.

Letter from the Editor

Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine.

Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India

The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies

Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity.

Pneumococcal Vaccination Strategies. An Update and Perspective.

Retention of a vaginal ring pessary in a postmenopausal patient.

Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.

Group B streptococcal infections in elderly adults.

Similar Documents

Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.

Letter from the Editor

Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine.

Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India

The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies

Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity.

Pneumococcal Vaccination Strategies. An Update and Perspective.

Retention of a vaginal ring pessary in a postmenopausal patient.

Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.

Group B streptococcal infections in elderly adults.